Feeds from Toronto StarAdventure TravelAll Sci Tech stories Ann Douglas: Parenting Antonia Zerbisias: Broadsides Argos Football Beach and Sun Brandie Weikle: ParentCentral editor Cam Harvey: Global Finance Canada CD reviews Chris Zelkovich: Sports Media Watch Cruising Damien Cox: The Spin David Bruser: Fitness blog David Grossman: High School Sports David Olive: Everybody's Business Doug Smith: Toronto Raptors blog DVD reviews Editorials Environment Event listings Family Vacations Fashion & Style Food Global Voices Insight Jays Baseball Jennifer Speedy: YourHome editor Jim Byers: Travel Jim Kenzie: The Driver's Seat John Leblanc: Crank Wheels.ca John Terauds: Sound Mind Leafs Hockey Linda Diebel: Political Decoder Malene Arpe: Stargazing Michelle Henry: Pregnant Pause Movies Murray Whyte: Contemporary art News alerts Ontario Outings Patrick Cain: Map of the Week Randy Starkman: Olympics Raptors Hoops Religion Restaurants Richard Griffin: Baseball Sandy Naiman: Coming Out Crazy Science Shopping Skiing Stuart Laidlaw: Medical ethics Technology Television Top Business stories Top Entertainment stories Top Living stories Top News stories Top Sci Tech stories Top Sports stories Top stories Top Travel stories Top wheels.ca stories Toronto FC Soccer Twitter.com StarSports Video game reviews What's On World All Feeds |
Stuart Laidlaw: Medical ethics - Feed
Find the latest news stories from Toronto Star on the topic Stuart Laidlaw: Medical ethics. |
 Questions raised about Avandia testsDespite government investigations into the safety of diabetes drug Avandia, test subjects are still being recruited for studies into the controverial drug, according to a report. That has some researchers scratching their heads, since regulators in Canada and the US...
|
 Autism and snake oilFor me, one of the most interesting things about the retraction last week by the Lancet of its discredited 1998 study linking vaccines and autism was the consensus that those who have believed the study will continue to have faith...
|
 Peering over the edge into assisted suicideIn today's Toronto Star, I address the issue of assisted suicide -- and the argument that euthanasia is practiced so often in hospitals in all but name, that we should consider simply legalizing it. Starving to death in a hospital...
|
 Only one-quarter of U.S. medical centres ban ghostwritingA new study released today shows only 26 per cent of top American medical centres have a ban on the use of ghostwriters by their researchers. The study, released today by PLoS Medicine, surveyed 50 top medical centres across the...
|
 Science as marketingA new peer-reviewed study paints a disturbing picture of the use and abuse of science by pharmaceutical companies to help them sell drugs. Published in the latest edition of the Journal of Bioethical Inquiry, the study goes through several case...
|
 More on salami slicing -- Cymbalta ads ordered pulledToday, I had a story in the Toronto Star about an issue I touched on in this blog last week: Salami slicing, or the re-use of clinical trial data in more than one journal study. I spoke to Glen Spielmans,...
|
 Few actually need antidepressants, study findsIt seems that despite the efforts of big drug companies to mass market their antidepressants -- turning them into blockbuster druggs as they pitch the pills to children and pregnant women -- only the severly depressed actually benefit, a new...
|
 A thin slice of (antidepressant) salamiA new study is casting a light on the controversial practice in academic publishing of "salami slicing" -- or the publication of several studies from just one set of clinical data. Blogger and award-winning reporter Ed Silverman defines salami slicing...
|
 Medical journals act on conflicts of interestThe world's top medical journals, including the Canadian Medical Association Journal, have launched a beta version of a new financial disclosure form they will require future researchers to fill out before their studies can be published in their pages. According...
|
|
|
 Who best to regulate -- doctors or drug companies?A move by New Jersey to become the first state in the US to regulate the relationship of doctors to drug companies is sparking a debate over the best way to counter the power of Big Pharma. Last month, NJ...
|
